CD4 and melanoma: Analyzing the expression of the early activation marker of T‐cells, CD69, a significant increase was observed for the Ar/O2, He, and He/O2 conditions when comparing splenic CD4+ T‐cells cultured in the presence or absence of melanoma cells (Figure 3g).